Previous studies suggested that IDH1 mutation is a powerful prognostic marker for gliomas [28], and it is also considered as a predictive biomarker for extensive surgical resection, radiotherapy and chemotherapy in gliomas [29]. Here, IDH1 is linked to glioma.